Second International Symposium on Acute Promyeloctic Leukemia: A Curable Disease, Rome, 12-14 November 1997

Leukemia

Volumn 12, Issue 12, 1998, Pages 1866-1880

  Lo Coco, F ^a   Nervi, C ^a   Avvisati, G ^a   Mandelli, F ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Acute promyelocytic leukemia; All trans retinoic acid; PML RAR

Indexed keywords

ARSENIC TRIOXIDE; ORGANOARSENIC DERIVATIVE; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID; ANTINEOPLASTIC AGENT; NUCLEAR PROTEIN; OXIDE; PML PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ACUTE MYELOBLASTIC LEUKEMIA; BLOOD CLOTTING DISORDER; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CLINICAL TRIAL; CONFERENCE PAPER; CYTOGENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOPHENOTYPING; LEUKEMOGENESIS; MINIMAL RESIDUAL DISEASE; ONCOGENE; PRIORITY JOURNAL; RETINOIC ACID SYNDROME; AGED; CHILD; DRUG RESISTANCE; GENETICS; ITALY; KARYOTYPING; METABOLISM; PROMYELOCYTIC LEUKEMIA; RECURRENT DISEASE; RESEARCH;

AGED; ANTINEOPLASTIC AGENTS; ARSENICALS; CHILD; DRUG RESISTANCE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOPHENOTYPING; KARYOTYPING; LEUKEMIA, PROMYELOCYTIC, ACUTE; NEOPLASM PROTEINS; NEOPLASM, RESIDUAL; NUCLEAR PROTEINS; OXIDES; RECURRENCE; RESEARCH; ROME; TRANSCRIPTION FACTORS; TRETINOIN; TUMOR SUPPRESSOR PROTEINS;

EID: 0032405602     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401230     Document Type: Conference Paper

References (11)

1. Grignani F, Fagioli M, Alcalay M, Longo L, Pandolfi PP, Donti E, Biondi A, Grignani F, Lo Coco F, Pelicci PG. Acute promyelocytic leukemia: from genetics to treatment. Blood 1994; 83: 10-25.
2. Chen S-J, Wang Z-Y, Chen Z. Acute promyelocytic leukemia: from clinic to molecular biology. Stem Cells 1995; 13: 22-31.
3. Warrell RP Jr. Pathogenesis and management of acute promyelocytic leukemia. Annu Rev Med 1996; 47: 555-565.
4. Fenaux P, Chomienne C, Degos L. Acute promyelocytic leukemia: biology and treatment. Semin Oncol 1997; 24: 92-102.
5. Slack JL. Recent advances in the biology and treatment of acute promyelocytic leukemia. Educational Book of the 34th Meeting of the American Society of Clinical Oncology, Los Angeles, CA 1998, pp 54-65.
6. Chen Z, Brand NJ, Chen A, Chen S-J, Tong JH, Wang Z-Y, Waxman S, Zelent A. Fusion between a novel Kruppel-like zinc finger gene and retinoic acid receptor-α locus due to a variant t(11;17) translocation associated with acute promyelocytic leukemia. EMBO J 1993; 12: 1161-1167.
7. Redner RL, Rush EA, Faas S, Rudert WA, Corey SJ. The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion. Blood 1996; 87: 882-886.
8. Wells RA, Catzavelos C, Kamel-Reid S. Fusion of retinoic acid receptor α to NUMA, the nuclear mitotic apparatus protein, by a variant translocation in acute promyelocytic leukemia. Nat Genet 1997; 17: 109-113.
9. Mangelsdorf DJ, Umesono K, Evans RM. The retinoid receptors. In: Sporn MB, Roberts AB, Goodman DS (eds). The Retinoids: Biology, Chemistry, and Medicine. Raven Press: New York, 1994, pp 319-349.
10. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J 1996; 10: 940-954.
11. Nervi C, Grippo JF, Sherman MI, George MD, Jetten AM. Identification and characterization of nuclear retinoic acid-binding activity in human myeloblastic leukemia HL-60 cells. Proc Natl Acad Sci USA 1989; 86: 5854-5858.